Catalyst Pharmaceuticals (CPRX) Shareholder's Equity Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.50% |
| Dec 31, 2025 | 31.15% |
| Sep 30, 2025 | 39.23% |
| Jun 30, 2025 | 40.64% |
| Mar 31, 2025 | 41.48% |
| Dec 31, 2024 | 87.59% |
| Sep 30, 2024 | 89.63% |
| Jun 30, 2024 | 62.18% |
| Mar 31, 2024 | 68.26% |
| Dec 31, 2023 | 29.11% |
| Sep 30, 2023 | 29.07% |
| Jun 30, 2023 | 55.66% |
| Mar 31, 2023 | 51.51% |
| Dec 31, 2022 | 45.25% |
| Sep 30, 2022 | 35.93% |
| Jun 30, 2022 | 27.60% |
| Mar 31, 2022 | 23.27% |
| Dec 31, 2021 | 21.95% |
| Sep 30, 2021 | 26.84% |
| Jun 30, 2021 | 69.91% |
| Mar 31, 2021 | 79.23% |
| Dec 31, 2020 | 93.54% |
| Sep 30, 2020 | 100.85% |
| Jun 30, 2020 | 75.72% |
| Mar 31, 2020 | 94.77% |
| Dec 31, 2019 | 72.55% |
| Sep 30, 2019 | 21.70% |
| Jun 30, 2019 | -10.95% |
| Mar 31, 2019 | -32.88% |
| Dec 31, 2018 | -37.27% |
| Sep 30, 2018 | 101.95% |
| Jun 30, 2018 | 109.20% |
| Mar 31, 2018 | 117.25% |
| Dec 31, 2017 | 105.97% |
| Sep 30, 2017 | -26.04% |
| Jun 30, 2017 | -26.67% |
| Mar 31, 2017 | -30.55% |
| Dec 31, 2016 | -29.14% |
| Sep 30, 2016 | -29.26% |
| Jun 30, 2016 | -26.22% |
| Mar 31, 2016 | -24.14% |
| Dec 31, 2015 | 57.41% |
| Sep 30, 2015 | 65.61% |
| Jun 30, 2015 | 52.45% |
| Mar 31, 2015 | 277.71% |
| Dec 31, 2014 | 64.75% |
| Sep 30, 2014 | 65.57% |
| Jun 30, 2014 | 318.39% |
| Dec 31, 2013 | 46.29% |
| Dec 31, 2012 | 288.81% |
| Dec 31, 2011 | -31.84% |